user avatar
10x Genomics
@10xGenomics
Enabling researchers to answer biology’s hardest and most elusive questions with innovative #singlecell, #spatialbiology & #insitu technology
Pleasanton, CA
10xgen.com/tw-home
Joined October 2014
668
Following
28.7K
Followers
Posts
  • user avatar
    10x Genomics
    @10xGenomics
    Dec 23, 2024
    🎉 Congrats to the Singapore research team on ezSingleCell! 🎉 A game-changer for #singlecell & #spatialbiology, it simplifies data analysis from platforms like Chromium, Visium & Xenium without programming expertise! 🚀 Learn more: nature.com/articles/s4146…
    27K
  • user avatar
    10x Genomics
    @10xGenomics
    Feb 24, 2020
    KB: So today we are pleased to introduce the Chromium Single Cell ATAC + Gene Expression solution. 2 modalities in one simple workflow, both at high sensitivity. #AGBT20
  • user avatar
    10x Genomics
    @10xGenomics
    Jul 24, 2023
    IYKYK
    50K
  • user avatar
    10x Genomics
    @10xGenomics
    Jun 4, 2019
    We are excited to announce the release of our large-scale #immunology dataset. The dataset, using over 150k CD8+ T cells from 4 human donors, analyzed 44 specific antigens. We hope it enables a new way of exploring adaptive immunity. bit.ly/2Z56kJt
  • user avatar
    10x Genomics
    @10xGenomics
    Apr 10, 2022
    Observe tumor biology in its native tissue with high-resolution, high-target in situ analysis. Get your first look at the upcoming Xenium In Situ platform at Booth 3340 @AACR #AACR22
  • user avatar
    10x Genomics
    @10xGenomics
    Mar 24, 2021
    Spatially resolved transcriptomics publications are on the rise! With so many papers and not enough time to read them all, where should you start? We’ve got a list of exciting recent publications featuring spatial transcriptomics. Learn more on our blog. bit.ly/3fd5xBp
  • user avatar
    10x Genomics
    @10xGenomics
    Jun 21, 2019
    The art of #SingleCell analysis. #FridayFunny
  • user avatar
    10x Genomics
    @10xGenomics
    Sep 12, 2019
    A new public company, yet another milestone on our path to mastering biology to advance human health. This is the Century of Biology. #10xGenomicsIPO #CenturyofBiology $TXG @NASDAQ
  • user avatar
    10x Genomics
    @10xGenomics
    Sep 13, 2019
    Excited to celebrate our #10xGenomicsIPO on @Nasdaq today. The Century of Biology is here and we are thrilled to be a part of it. Thank you once again to our customers, investors and our team!
    00:00
  • user avatar
    10x Genomics
    @10xGenomics
    Jan 10, 2024
    We’re excited to announce that #VisiumHD is now available for pre-orders, offering: ✅ Whole transcriptome spatial analysis at single cell scale ✅ Continuous tissue coverage (really, no gaps!) ✅ Best-in-class data Enter the HD era to see for yourself: bit.ly/3RVEnki
    00:00
    16K
  • user avatar
    10x Genomics
    @10xGenomics
    Dec 9, 2022
    Breaking 🗞: The first Xeniums are heading out into the world! We can’t wait to see what insights they uncover. Want to level up your research? See how Xenium lets you map 100s of RNA targets with subcellular resolution & reserve yours today: 10xgen.com/3YaXhG6
  • user avatar
    10x Genomics
    @10xGenomics
    Oct 4, 2023
    Combined #singlecell & #spatialtranscriptomics analysis of 300,000 single cell transcriptomes & 400 patient samples produced the most detailed picture of heterogeneous T cells in the tumor microenvironment to date. Explore the published resource ➡️ go.nature.com/48vPMyJ
    11K
  • user avatar
    10x Genomics
    @10xGenomics
    Aug 4, 2020
    Join our upcoming webinar and explore how you can simultaneously profile the #transcriptome and #epigenome from the same #singlecell to gain #multiomic insights into biological complexity. Register now: bit.ly/3a6PMYx
  • user avatar
    10x Genomics
    @10xGenomics
    Sep 12, 2019
    Thank you to our customers, employees and investors for getting us to today. With over 500 scientific papers published using 10x, we can’t wait to achieve even more in the coming decades. #CenturyOfBiology $TXG #10xGenomicsIPO